The International Journal of Tuberculosis and Lung Disease

Embracing the challenges of HIV-TB co-infection in children [Editorial]
pp. 379-379(1)
Authors: van Leth, Frank; Kampmann, Beate

Towards elimination in industrialised countries: expanding diagnosis and treatment of LTBI among immigrants [Editorial]
pp. 380-380(1)
Authors: White, Richard G.; Houben, Rein M. G. J.

Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire
pp. 381-387(7)
Authors: Auld, A. F.; Tuho, M. Z.; Ekra, K. A.; Kouakou, J.; Shiraishi, R. W.; Adjorlolo-Johnson, G.; Marlink, R.; Ellerbrock, T. V.

The effect of topical calcipotriol or zinc on tuberculin skin tests in hospitalised South African children
pp. 388-393(6)
Authors: Lala, S. G.; Parbhoo, K. B.; Verwey, C.; Khan, R.; Dangor, Z.; Moore, D.; Pettifor, J. M.; Martinson, N. A.

Non-response to the intensive phase of anti-tuberculosis treatment in children: evaluation and outcome [Short Communication]
pp. 394-396(3)
Authors: Yadav, A.; Sethi, G. R.; Mantan, M.; Dhingra, D.

Aligning US health and immigration policy to reduce the incidence of tuberculosis
pp. 397-404(8)
Authors: Blewett, L. A.; Marmor, S.; Pintor, J. K.; Boudreaux, M.

Preventing tuberculosis in the foreign-born population of Canada: a mathematical modelling study
pp. 405-412(8)
Authors: Varughese, M. B.; Langlois-Klassen, D.; Long, R.; Li, M.

Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands
pp. 413-420(8)
Authors: Erkens, C. G. M.; Dinmohamed, A. G.; Kamphorst, M.; Toumanian, S.; van Nispen-Dobrescu, R.; Alink, M.; Oudshoorn, N.; Mensen, M.; van den Hof, S.; Borgdorff, M.; Verver, S.

Risk factors for treatment default in close contacts with latent tuberculous infection
pp. 421-427(7)
Authors: Fiske, C. T.; Yan, F-X.; Hirsch-Moverman, Y.; Sterling, T. R.; Reichler, M. R.; the Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team.

The ‘either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment
pp. 428-434(7)
Authors: Jung, Y. J.; Lee, J. Y.; Jo, K-W.; Yoo, B.; Lee, C-K.; Kim, Y-G.; Yang, S-K.; Byeon, J-S.; Kim, K-J.; Ye, B. D.; Lee, K-H.; Lee, S-D.; Kim, W. S.; Kim, D. S.; Shim, T. S.

Impact of the Xpert^® MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis [Short Communication]
pp. 435-437(3)
Authors: Buchelli Ramirez, H. L.; García-Clemente, M. M.; Álvarez-Álvarez, C.; Palacio-Gutierrez, J. J.; Pando-Sandoval, A.; Gagatek, S.; Arias-Guillén, M.; Quezada-Loaiza, C. A.; Casan-Clará, P.

Successes, challenges and lessons from a novel deployment of Xpert^® MTB/RIF at a major South African public event [Short Communication]
pp. 438-440(3)
Authors: Page-Shipp, L.; Stevens, W.; Clark, D.; Scott, L.; Olsen, F.; Kisbey-Green, H.; Mametja, D.; Churchyard, G.

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa
pp. 441-448(8)
Authors: Cox, H.; Hughes, J.; Daniels, J.; Azevedo, V.; McDermid, C.; Poolman, M.; Boulle, A.; Goemaere, E.; van Cutsem, G.

Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
pp. 449-453(5)
Authors: Kumar, R. S.; Kumar, A. M. V.; Claassens, M.; Banurekha, V. V.; Sekar, G.; Venkatesan, P.; Swaminathan, S.

Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany
pp. 454-460(7)
Authors: Napiórkowska, A.; Rüsch-Gerdes, S.; Hillemann, D.; Richter, E.; Augustynowicz-Kopeć, E.

Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China
pp. 461-465(5)
Authors: Huang, Z-K.; Luo, Q.; Xiong, G-L.; Li, W-T.; Xu, X-M.; Li, J-M.

Change in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status [Short Communication]
pp. 466-469(4)
Authors: Hasan, Z.; Salahuddin, N.; Rao, N.; Aqeel, M.; Mahmood, F.; Ali, F.; Ashraf, M.; Rahman, F.; Mahmood, S.; Islam, M.; Dildar, B.; Anwer, T.; Oiighor, F.; Sharif, N.; Ullah, A. R.

Value of procalcitonin in differentiating pulmonary tuberculosis from other pulmonary infections: a meta-analysis
pp. 470-477(8)
Authors: Huang, S-L.; Lee, H-C.; Yu, C-W.; Chen, H-C.; Wang, C-C.; Wu, J-Y.; Lee, C-C.

Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine
pp. 478-485(8)
Authors: Fortún, J.; Martín-Dávila, P.; Gómez-Mampaso, E.; González-García, A.; Barbolla, I.; Gómez-García, I.; Wikman, P.; Ortíz, J.; Navas, E.; Cuartero, C.; Gijón, D.; Moreno, S.

Predictors of paradoxical tuberculoma in tuberculous meningitis
pp. 486-491(6)
Authors: Kalita, J.; Prasad, S.; Misra, U. K.

Smoking increases risk of recurrence after successful anti-tuberculosis treatment: a population-based study
pp. 492-498(7)
Authors: Yen, Y-F.; Yen, M-Y.; Lin, Y-S.; Lin, Y-P.; Shih, H-C.; Li, L-H.; Chou, P.; Deng, C-Y.

Home environmental tobacco smoke exposure in Canadian children
pp. 499-504(6)
Authors: Slogrove, A. L.; Bettinger, J. A.